Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
90 participants
INTERVENTIONAL
2024-09-01
2026-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Dexmedetomidine on Postoperative Delirium Inflammasome Activation Inhibition
NCT03588988
Ketofol for Preventing Postoperative Delirium in Elderly Patients
NCT04816162
Delirium at the Intensive Care Unit - a Retrospective Cohort Study
NCT02603731
Development of Delirium in Patients Undergoing Open-Heart Surgery
NCT06195592
Post Operative Delirium Study
NCT04635774
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interventional group: Cyclic enteral nutrition with ketogenic nighttime fasting
Interventional group: Cyclic enteral daytime nutrition (12 hours) with ketogenic nighttime fasting (12 hours) with supplementation of exogenous ketones (ß-hydroxybutyrate) in the Intensive Care Setting.
Cyclic enteral daytime feeding with ketogenic nighttime fasting and exogenous ketone salt supplementation (ß-hydroxybutyrate)
Nighttime fasting and ß-hydroxybutyrate supplementation
Control group: Conventional continuous enteral nutrition
Continuous (24 hours) enteral nutrition in the Intensive Care Setting.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cyclic enteral daytime feeding with ketogenic nighttime fasting and exogenous ketone salt supplementation (ß-hydroxybutyrate)
Nighttime fasting and ß-hydroxybutyrate supplementation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admission to an ICU
* Start of enteral nutrition
Exclusion Criteria
* Post total Pancreatectomy / Insulin-depending diabetes mellitus (IDDM)
* Pregnancy / Lactation
* Hemoglobin-concentration \< 80g/l
* Severe metabolic disorder / severe autoimmune disease
* Refractory respiratory or metabolic acidosis
* Disorder of mitochondrial transportation of fatty acids
* Disorder of the oxidation of fatty acids
* Disorder of gluconeogenesis, der ketone body production or ketone body degradation
* Intermittent porphyria
* Severe arrhythmia / cardiomyopathy
* Contraindications against enteral nutrition
* Missing informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital of Cologne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sandra Emily Stoll
MD, Ass. Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bernd W Böttiger, Prof
Role: STUDY_DIRECTOR
University Hospital Cologne
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-1398_2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.